Month: August 2025
NY cannabis program ruling could add to legal case for interstate commerce
The Second Circuit ruling has essentially zero immediate impact for stakeholders in the New York cannabis market, since it doesn’t…
This Cannabis Stock Popped 26% Today After Announcing Partnership With An Italian Company – Do You Own It?
Tilray Brands’ (TLRY) shares soared over 26% by Wednesday afternoon after Tilray Medical announced that its wholly-owned subsidiary has entered…
Rescheduling Should Send MJ And MSOS Sky High
Cannabis ETFs MJ and MSOS are surging on rescheduling speculation that Trump will reclassify marijuana as a Schedule III drug….
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the…
Why cannabis insurability depends on the story you tell
Operators who humanize their risk profile are finding more receptive underwriters and better terms, says Kelli Hunt …
Why This Cannabis Penny Stock Could Be Wall Street’s Next Meme Trade Breakout
The cannabis industry has been through one of the longest bear markets in recent history. But in the past few…
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of…
Editorial: Is it finally time for legal marijuana in Pennsylvania?
President Donald Trump is mulling a move on marijuana. The president said Monday his administration was considering rescheduling the substance,…
If You’d Invested $1,000 in Trulieve Cannabis (TCNNF) 3 Years Ago, Here’s How Much You’d Have Today
The price nose-dived by nearly 40%, and it was hardly the worst performer among its peer group.
How Trump could steal marijuana policy from the liberals
President Trump is opening the door to reclassifying marijuana, potentially allowing the GOP to claim another health issue that’s long…
Recent Comments